Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Compumedics Limited (AU:CMP)
ASX:CMP
Compumedics Limited (CMP) Share Price & Analysis
1 Followers
CMP Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.15 - AU$0.45
Previous CloseAU$0.32
Volume2.07K
Average Volume (3M)33.99K
Market Cap
AU$58.81M
Enterprise ValueAU$58.06M
Total Cash (Recent Filing)AU$7.29M
Total Debt (Recent Filing)AU$6.55M
Price to Earnings (P/E)45.7
Beta1.09
Next Earnings
Sep 02, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding177,162,948
10 Day Avg. Volume116,884
30 Day Avg. Volume33,986
Standard Deviation0.24
R-Squared0.09
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Compumedics Limited News
PremiumCompany Announcements
Compumedics Limited Celebrates Record-Breaking Year
PremiumCompany Announcements
Compumedics Issues Shares to Investors
PremiumCompany Announcements
Compumedics Seeks Quotation for New SharesPremiumCompany Announcements
Compumedics Plans New Securities IssuancePremiumCompany Announcements
Compumedics Secures $1.9M for Sleep Test Expansion
PremiumCompany Announcements
Compumedics Limited Announces Trading HaltPremiumCompany Announcements
Compumedics Expands U.S. Team, Targets Sleep Tech MarketPremiumCompany Announcements
Compumedics Targets Growth and Market Re-RateOptions Prices
Currently, No data available
---
Ownership Overview
55.26%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
44.74% Public Companies and
Individual Investors
CMP FAQ
What was Compumedics Limited’s price range in the past 12 months?
Compumedics Limited lowest share price was AU$0.14 and its highest was AU$0.45 in the past 12 months.
What is Compumedics Limited’s market cap?
Currently, no data Available
When is Compumedics Limited’s upcoming earnings report date?
Compumedics Limited’s upcoming earnings report date is Sep 02, 2024 which is in 41 days.
How were Compumedics Limited’s earnings last quarter?
Compumedics Limited released its earnings results on Feb 29, 2024. The company reported AU$0.001 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.001.
Is Compumedics Limited overvalued?
According to Wall Street analysts Compumedics Limited’s price is currently Overvalued.
Does Compumedics Limited pay dividends?
Compumedics Limited does not currently pay dividends.
What is Compumedics Limited’s EPS estimate?
Compumedics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Compumedics Limited have?
Compumedics Limited has 183,770,100 shares outstanding.
What happened to Compumedics Limited’s price movement after its last earnings report?
Compumedics Limited reported an EPS of AU$0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Compumedics Limited?
Currently, no hedge funds are holding shares in AU:CMP
---
Compumedics Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
72.97%
12-Months-Change
Fundamentals
Return on Equity
7.07%
Trailing 12-Months
Asset Growth
2.58%
Trailing 12-Months
Company Description
Compumedics Limited
Compumedics Ltd is a medical device company. It is engaged in the development, manufacture, and commercialisation of diagnostic technologies for the sleep, brain and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and the Asia Pacific, and Europe. It derives a majority of revenue from Australia and the Asia Pacific region.
---
Technical Analysis
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
OncoSil Medical Ltd
―
Prescient Therapeutics Limited
―
---